Gilead Sciences Inc. Earnings

Gilead Sciences Inc.’s revenue jumped 6.38% since last year same period to $7569Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 0.32% jump in its revenue since last 3-months.

Gilead Sciences Inc.’s net profit jumped 24.77% since last year same period to $1783Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 42.3% jump in its net profits since last 3-months.

Gilead Sciences Inc.’s net profit margin jumped 17.29% since last year same period to 23.56% in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 41.85% jump in its net profit margins since last 3-months.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.7 - a 9.71% jump from last quarter’s estimates.

Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.7.

Gilead Sciences Inc.’s earning per share (EPS) jumped 10.47% since last year same period to 1.9 in the Q4 2024. This indicates that the Gilead Sciences Inc. has generated 10.47% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Gilead Sciences Inc. declared 0.77 dividend per share during the earnings announcement for Q4 2024.